VXRT - Vaxart Inc. (VXRT) Q4 2023 Earnings Call Transcript
2024-03-14 19:03:09 ET
Start Time: 16:30
End Time: 17:00
Vaxart, Inc. (VXRT)
Q4 2023 Earnings Conference Call
March 14, 2024, 16:30 PM ET
Company Participants
Michael Finney - Interim CEO
Sean Tucker - SVP and Chief Scientific Officer
James Cummings - Chief Medical Officer
Phil Lee - CFO
Edward Berg - SVP and General Counsel
Conference Call Participants
Liang Cheng - Jefferies
Madison Britt Wynne El-Saadi - B. Riley Securities
Presentation
Operator
Greetings, and welcome to the Vaxart Business Update and Full Year 2023 Financial Results Conference Call. A question-and-answer session will follow management's opening remarks. Individual investors may submit written questions to ir@vaxart.com. As a reminder, this conference is being recorded.
I would now like to turn the webcast over to your host, Ed Berg, Senior Vice President and General Counsel.
Edward Berg
Good afternoon, and welcome to today's call. Joining us from Vaxart are Dr. Michael Finney, Interim Chief Executive Officer; Dr. Sean Tucker, SVP and Chief Scientific Officer; Dr. James Cummings, Chief Medical Officer; and Phil Lee, Chief Financial Officer....
Vaxart, Inc. (VXRT) Q4 2023 Earnings Call Transcript